CTOs on the Move

Respicardia

www.respicardia.com

 
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.respicardia.com
  • 12400 Whitewater Dr Suite 150
    Minnetonka, MN USA 55343
  • Phone: 952.540.4470

Executives

Name Title Contact Details

Funding

Respicardia raised $58.5M on 12/19/2017

Similar Companies

Armm Inc

ARMM, Inc. offers high quality disposable medical devices and contract services at reasonable cost with short response times. ARMM can assist with every stage of your project. All production, manufacturing, and assembly processes are in certified clean

Graham Field Health Products

GF Health Products, headquartered in Atlanta, Ga., is a major manufacturer and distributor of healthcare products for homecare, long-term care, primary care and acute care markets. Its products include medical/surgical products, diagnostics, patient room

www.biosig.com

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.

Episode Solutions

Episode Solutions provides resources and services, tailored exclusively to the needs of musculoskeletal physicians and physicians groups, to help evaluate and maximize physician performance in alternative payment structures, without sacrificing existing professional fee-for-service revenue. Episode Solutions provides the platform that enables MSK physicians to take advantage of the substantial opportunities to create and share in immediate savings through bundled payments.

Burkhart Roentgen International

Burkhart Roentgen International is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.